Our look is new. Our purpose is the same. Learn more about our brand evolution.
[…] one more time before ‘going public’ with it, or at least run it by an FSHD clinician who practices Western medicine. Today I can confidently say that I’ve met the […]
[…] the identification of compounds showing activity as a potential treatment to stop the progression of FSHD. This agreement marks the start of finding a drug to overcome FSHD. Facio’s drug […]
[…] the U.S. Food and Drug Administration (FDA) for the treatment of facioscapulohumeral muscular dystrophy ( FSHD). Resolaris, an investigational new drug representing aTyr’s first Physiocrine-based product candidate in the clinic, is […]
[…] Lynn Photography. Ryan Levinson, of San Diego California, was diagnosed with Fascioscapulohumeral muscular dystrophy ( FSHD) in 1996. Though he suffers from muscle loss typical of most people with FSHD, […]
[…] organization that has transformed the science of the rare incurable disease, facioscapulohumeral muscular dystrophy ( FSHD), today announced its Honorary Board. The board of fourteen distinguished celebrities will work in […]
